Therapeutic Action
Antiretroviral, nucleoside reverse transcriptase inhibitor
Source page 189
Loading InternPractice…
Individual generic drug information
Extracted information for LAMIVUDINE only.
Antiretroviral, nucleoside reverse transcriptase inhibitor
Source page 189
HIV infection, in combination with other antiretrovirals
Source page 189
Extracted information for LAMIVUDINE only.
Administer with caution to patients with history of hepatic disorders. May cause: gastrointestinal disturbances (diarrhoea, nausea, vomiting, etc.) and possibly: haematological disorders, especially when combined with zidovudine (neutropenia, anaemia, thrombocytopenia), myopathy, hepatic or pancreatic disorders. Reduce dosage in patients with renal impairment. Pregnancy: no contra-indication
Source page 190
Extracted information for LAMIVUDINE only.
150 mg tablet 50 mg/5 ml oral solution
Source page 189
The daily dose is administered once daily or in 2 divided doses. Child 1 month and over and adult: Weight Daily dose 50 mg/5 ml oral sol. 150 mg tablet 3 to < 6 kg 60 mg 3 ml x 2 – 6 to < 10 kg 80 mg 4 ml x 2 – 10 to < 14 kg 120 mg 6 ml x 2 – ½ tab x 2 14 to < 20 kg 150 mg – or 1 tab x 1 ½ tab morning and 1 tab evening 20 to < 25 kg 225 mg – or 1 ½ tab x 1 1 tab x 2 ≥ 25 kg 300 mg – or 2 tab x 1
Source page 189
Depending on the efficacy and tolerance of lamivudine.
Source page 190
Extracted information for LAMIVUDINE only.
In neonates, the dosage of lamivudine 50 mg/5 ml (i.e. 10 mg/ml) solution is: 2 to < 3 kg: 0.5 ml 2 times daily (daily dose: 10 mg) 3 to < 4 kg: 0.8 ml 2 times daily (daily dose: 16 mg) 4 to < 5 kg: 1 ml 2 times daily (daily dose: 20 mg) Lamivudine is also used for HIV post-exposure prophylaxis, in combination with other antiretrovirals. Also comes in fixed-dose combinations with other antiretrovirals. Preferably use these formulations when available.
Source page 190
Below 25 °C Once opened, oral solution keeps for 30 days maximum.
Source page 190
Filter the extracted dose blocks for this individual drug.